Norges Bank Intra Cellular Therapies, Inc. Transaction History

Norges Bank

  • $716 Trillion
  • Q3 2024

Shares

48 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$64.76 - $79.84 $126 Million - $155 Million
1,943,730 New
1,943,730 $133 Million
Q4 2023

Feb 09, 2024
BUY
$46.37 - $73.65 $55.5 Million - $88.2 Million
1,197,203 New
1,197,203 $85.7 Million
Q3 2023

Nov 13, 2024
BUY
$52.09 - $64.1 $42.7 Million - $52.6 Million
820,416 New
820,416 $42.7 Million
Q3 2023

Nov 13, 2023
SELL
$52.09 - $64.1 $45 Million - $55.3 Million
-862,933 Closed
0 $0
Q2 2023

Aug 14, 2024
SELL
$54.67 - $66.44 $62.7 Million - $76.2 Million
-1,147,146 Reduced 59.02%
796,584 $50.4 Million
Q2 2023

Aug 14, 2023
SELL
$54.67 - $66.44 $43.7 Million - $53.2 Million
-800,230 Closed
0 $0
Q1 2023

May 15, 2024
BUY
$43.8 - $56.99 $41.9 Million - $54.5 Million
957,181 New
957,181 $51.8 Million
Q4 2022

Feb 14, 2023
BUY
$44.07 - $54.45 $45.9 Million - $56.7 Million
1,041,874 New
1,041,874 $55.1 Million
Q3 2022

Nov 13, 2023
BUY
$42.7 - $59.99 $36.8 Million - $51.8 Million
862,933 New
862,933 $40.2 Million
Q2 2022

Aug 14, 2023
BUY
$43.0 - $65.64 $34.4 Million - $52.5 Million
800,230 New
800,230 $45.7 Million
Q1 2022

May 12, 2023
SELL
$38.74 - $62.09 $15.6 Million - $25.1 Million
-403,932 Reduced 38.77%
637,942 $39 Million
Q1 2022

May 09, 2022
SELL
$38.74 - $62.09 $22.6 Million - $36.2 Million
-583,207 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$35.2 - $53.42 $20.5 Million - $31.2 Million
583,207 New
583,207 $30.5 Million
Q3 2021

Nov 14, 2022
BUY
$28.72 - $42.49 $10.3 Million - $15.2 Million
357,588 New
357,588 $13.3 Million
Q3 2021

Nov 05, 2021
SELL
$28.72 - $42.49 $12.3 Million - $18.2 Million
-428,485 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$29.3 - $44.5 $12.6 Million - $19.1 Million
428,485 New
428,485 $17.5 Million
Q2 2021

Aug 10, 2021
SELL
$29.3 - $44.5 $8.23 Million - $12.5 Million
-281,035 Closed
0 $0
Q1 2021

May 09, 2022
BUY
$30.8 - $39.51 $8.66 Million - $11.1 Million
281,035 New
281,035 $9.54 Million
Q1 2021

May 07, 2021
SELL
$30.8 - $39.51 $16.2 Million - $20.8 Million
-527,281 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$23.34 - $32.22 $12.3 Million - $17 Million
527,281 New
527,281 $16.8 Million
Q4 2020

Feb 10, 2021
SELL
$23.34 - $32.22 $8.18 Million - $11.3 Million
-350,623 Closed
0 $0
Q3 2020

Nov 12, 2021
BUY
$17.61 - $31.86 $6.17 Million - $11.2 Million
350,623 New
350,623 $9 Million
Q3 2020

Nov 10, 2020
SELL
$17.61 - $31.86 $10.9 Million - $19.7 Million
-617,235 Closed
0 $0
Q2 2020

Aug 13, 2021
BUY
$14.35 - $26.64 $8.86 Million - $16.4 Million
617,235 New
617,235 $15.8 Million
Q2 2020

Aug 07, 2020
SELL
$14.35 - $26.64 $8.57 Million - $15.9 Million
-597,440 Closed
0 $0
Q1 2020

May 07, 2021
BUY
$12.31 - $33.12 $7.35 Million - $19.8 Million
597,440 New
597,440 $9.18 Million
Q1 2020

May 08, 2020
SELL
$12.31 - $33.12 $2.76 Million - $7.41 Million
-223,810 Closed
0 $0
Q4 2019

Mar 03, 2020
BUY
$7.26 - $38.49 $1.62 Million - $8.61 Million
223,810 New
223,810 $7.68 Million
Q4 2019

Feb 12, 2020
SELL
$7.26 - $38.49 $2.06 Million - $10.9 Million
-283,505 Closed
0 $0
Q3 2019

Nov 13, 2020
BUY
$7.47 - $14.03 $2.12 Million - $3.98 Million
283,505 New
283,505 $2.12 Million
Q3 2019

Nov 08, 2019
SELL
$7.47 - $14.03 $2.47 Million - $4.63 Million
-330,070 Closed
0 $0
Q2 2019

Aug 13, 2020
BUY
$10.65 - $14.29 $3.52 Million - $4.72 Million
330,070 New
330,070 $4.28 Million
Q2 2019

Aug 09, 2019
SELL
$10.65 - $14.29 $3.52 Million - $4.72 Million
-330,070 Closed
0 $0
Q4 2018

Mar 04, 2019
BUY
$10.36 - $20.96 $3.42 Million - $6.92 Million
330,070 New
330,070 $3.76 Million
Q4 2018

Feb 08, 2019
SELL
$10.36 - $20.96 $3.42 Million - $6.92 Million
-330,070 Closed
0 $0
Q3 2018

Nov 12, 2019
BUY
$17.77 - $22.9 $5.87 Million - $7.56 Million
330,070 New
330,070 $7.16 Million
Q3 2018

Nov 09, 2018
SELL
$17.77 - $22.9 $5.87 Million - $7.56 Million
-330,070 Closed
0 $0
Q2 2018

Aug 12, 2019
BUY
$17.33 - $23.4 $5.72 Million - $7.72 Million
330,070 New
330,070 $5.83 Million
Q2 2018

Jul 23, 2018
SELL
$17.33 - $23.4 $5.19 Million - $7 Million
-299,320 Closed
0 $0
Q1 2018

May 15, 2019
BUY
$15.16 - $25.49 $4.54 Million - $7.63 Million
299,320 New
299,320 $6.3 Million
Q1 2018

May 09, 2018
SELL
$15.16 - $25.49 $4.23 Million - $7.11 Million
-279,070 Closed
0 $0
Q4 2017

Mar 05, 2018
BUY
$14.27 - $16.79 $3.98 Million - $4.69 Million
279,070 New
279,070 $4.04 Million
Q4 2017

Feb 09, 2018
SELL
$14.27 - $16.79 $3.98 Million - $4.69 Million
-279,070 Closed
0 $0
Q3 2017

Nov 13, 2018
BUY
$10.77 - $22.1 $3.01 Million - $6.17 Million
279,070 New
279,070 $4.4 Million
Q3 2017

Nov 07, 2017
SELL
$10.77 - $22.1 $1.82 Million - $3.74 Million
-169,070 Closed
0 $0
Q2 2017

Jul 24, 2018
SELL
N/A
-104,284 Reduced 38.15%
169,070 $2.1 Million
Q1 2017

May 11, 2018
SELL
N/A
-7,496 Reduced 2.67%
273,354 $4.44 Million
Q3 2016

Nov 13, 2017
BUY
N/A
280,850
280,850 $0

Others Institutions Holding ITCI

# of Institutions
381
Shares Held
84M
Call Options Held
319K
Put Options Held
143K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $11.9B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email